强耀生物科技
强耀生物
强耀生物
强耀生物科技version: English | 中文版
强耀生物科技
强耀生物科技
在线客服 
强耀生物科技
强耀生物科技
微信平台
强耀生物科技
手机网站

服务
产品强耀生物科技
强耀生物
您的位置:首页>> 产品 >> 常用产品

强耀生物科技 HIV Gag Peptide (199-207)
名称 HIV Gag Peptide (199-207)
别名
序列(单字母缩写) AMQMLKETI
序列(三字母缩写) {Ala}{Met}{Gln}{Met}{Leu}{Lys}{Glu}{Thr}{Ile}
基本描述 Using a strain of Listeria monocytogenes that stably expresses and secretes HIV gag to deliver this Ag to the MHC class I pathway of Ag processing, we have identified the immunodominant CTL epitope to gag in the BALB/c mouse and shown that it is Kd restricted. The specific motif for the peptides that bind the MHC class I molecule H-2 Kd is believed to be a nonamer with residues tyrosine or phenylalanine in the second amino acid position and leucine or isoleucine in the carboxyl-terminal or ninth amino acid position as dominant anchoring positions. Surprisingly, the identified gag peptide, AMQMLKETI, does not contain an anchoring aromatic residue in position two although competition assays with other Kd-restricted epitopes indicated that it binds to Kd with comparable affinity. Using a theoretical molecular dynamics approach to probe the stability of peptide binding to MHC class I molecules, we show that the absence of an appropriate anchor residue at P2 in AMQMLKETI is compensated by favorable interactions of the glutamine at P3 with pocket D of Kd. These findings were verified experimentally, demonstrating the predictive power of this theoretical approach in analyzing MHC class I/peptide interactions. These studies also indicate that CTL epitope prediction that relies on dominant peptide motifs may not always identify the correct epitope.
分子量 1064.330
化学式 C45H81N11O14S2
纯度 > 95%
存储条件
注释
Documents 文档
Figures
Reference


联系我们    |    人才招聘    |    关于我们    |    公司帐户   
联系电话:021-50795728 联系邮箱 inside@Chinapeptides.com
上海强耀生物科技有限公司 版权所有  沪ICP备16000238号